In clear cell renal cell carcinoma, IL-1β+ and IL-18+ Tregs co-localize with MRC1+FOLR2+ TAMs at tumor-normal interfaces, forming a positive feedback loop that sustains synergistic pro-tumor effects [97]. The gene discussed is MRC1; the disease is neoplasm.